NOV 11 - 12 2015
Clinical Diagnostics and Research
52 167 68121

Blah BlahWelcome to LabRoots’ 6th Annual Clinical Diagnostics & Research free online conference! The event is now available on-demand and you can attend sessions including keynotes sessions by Dr. Linda Thienpont, Katie Serrano, and Dr. Edward Watson Hook, III. Clinical diagnostics is an ever-changing field of medicine and research, challenged with combining several different scientific disciplines into one for the sake of diagnosis and treatment of human disease. Clinical diagnostics has become exciting in recent years as advances in new techniques aid in fulfilling the potential of personalized medicine.

Attendees can earn free CME and CE Credits while watching an impressive group of presenters who will discuss a range of medical, clinical and research topics including:

  • FDA regulation of Laboratory Developed Tests
  • Clinical application of LC-MS/MS
  • Clinical Next-generation Sequencing
  • Toxicology, Laboratory Test Utilization
  • Standardization of Laboratory medicine
  • New lipid lowering guidelines- helpful or harmful?
  • Clinical Genomics and Personalized Healthcare

Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global clinical community with a high degree of interaction through live-streaming video and chat sessions.

By bringing together clinicians, researchers, medical experts and professionals from around the world, LabRoots aims to help drive collaborations and in turn, advances in clinical diagnostics, research and medicine. This complementary conference offers an amazing opportunity to benefit from interacting with a global community of like-minded colleagues from the comfort of home.

Use #BCLclinical to follow the conversation

Continuing Education
The following are continuing medical education (CME) learner objectives that attendees should be able to do as a result of participating in this activity.

  • Ability to contrast previous and newly released guidelines
  • Take action to increase partnership and collaboration with clinicians
  • Identify actions that can be taken to deliver quality results faster to clinicians
  • Better define personalized healthcare today and explain the role of companion diagnostics
  • Better describe diagnostic tools used in the patient workups
  • Better describe how the evolution of laboratory testing in health has impacted the patient
  • Identify the role of the clinical laboratory in contributing to or preventing diagnostic errors
  • Identify laboratory directed interventions that can reduce diagnostic errors
  • Describe analytical issues associated with various assays
  • Recognize the patient safety risks associated with misuse of the clinical laboratory
  • Identify several categories of commonly misused laboratory tests
  • Advise patients on the likely long term effects of certain surgery in patients with diseases
  • Explain levels of personalized medicine as it attempts to predict individual response to therapy

Speakers:
  • Professor of Analytical Chemistry, Statistics and Quality Control, Method Development and Validation; Director of the Laboratory for Analytical Chemistry ID-MS Reference Laboratory, Universit
  • Professor of Internal Medicine, Director of the Division of Nephrology, Saint Louis University School of Medicine
  • Chief of the Division of Nephrology and Hypertension, and Director of Nephrology Research at NorthShore University HealthSystem and Clinical Professor of Medicine at the University of Chicago
  • Professor, Associated Laboratory Director, Saint-Luc University Hospital, Brussels, Belgium
  • Professor of Medicine/Epidemiology/Microbiology, Director, Division of Infectious Diseases, The University of Alabama at Birmingham, Department of Medicine, Division of Infectious Diseases
  • Senior Global Product Manager, NGS, Qiagen
  • Global Product Manager, NGS, QIAGEN
  • Chief, Division of Medical Genomics, Inova Translational Medicine Institute, Associate Professor, Virginia Commonwealth University School of Medicine
  • Application Scientist, Agilent Technologies
  • Assistant Professor, Department of Pediatrics, Division of Hematology/Oncology, University of Minnesota
  • Senior Manager, NGS Applications, DNASTAR
  • Deputy Director, Division of Chemistry and Toxicology Devices, Office of In Vitro Diagnostics and Radiological Health, Food and Drug Administration Center for Devices and Radiological Health
  • Chairman of Pathology, University of Texas Medical Branch
  • Project Lead for the Clinical Laboratory Integration into Health Care Collaboration (CLIHC), Division of Laboratory Programs, Standards, and Services Center for Surveillance, Epidemiology, an
  • Associate Director, Genetics and Solid Tumor Diagnostics Laboratory, Assistant Professor, Department of Laboratory Medicine, University of Washington
  • Clinical Chemistry Fellow, Department of Pathology, Johns Hopkins University School of Medicine
  • Associate Professor, University of Texas Health Science Center at San Antonio
  • Professor, Head of Laboratory, Microbiology and Immunology, Director, Microbiological Diagnostic Unit, University of Melbourne
  • Associate Professor of Pathology (Clinical), Medical Director of Informatics, ARUP Laboratories, University of Utah, Department of Pathology
  • Scientific Reviewer, Food and Drug Administration Center for Devices and Radiological Health
  • Co-Director, Cardiovascular Laboratory Medicine, Mayo Clinic
  • Professor of Endocrine Bone Research Laboratory, Univ of South Australia
  • Medical Director of Cardiac Rehabilitation and Stress Testing, Staff Cardiologist, Cleveland Clinic
  • Director, Endocrine Laboratory, Mayo Clinic
  • President, Medical Technology Partners
  • Clinical Associate Professor, Dept of Biochemistry, Royal Prince Alfred Hospital
  • Director of Clinical Chemistry, Houston Methodist Hospital, Associate Professor, Pathology and Laboratory Medicine, Weill Cornell Medical College

Show Resources
Agenda
All times are Pacific Time
  • NOV 11, 2015 06:00 AM PST
    Speaker: Ping Wang, PhD, DABCC, FACB
    SEE ABSTRACT | Continuing Education: CE
  • NOV 11, 2015 06:00 AM PST
    Speaker: Christina (Tina) Lockwood, PhD, DABCC, FACB
  • NOV 11, 2015 06:00 AM PST
    Speaker: Raed Samara, PhD
    SEE ABSTRACT | Continuing Education: CE
  • NOV 11, 2015 07:30 AM PST
    Speaker: Linda Thienpont, PhD, PHARM, Clinical Chemist
    SEE ABSTRACT | Continuing Education: CE
  • NOV 11, 2015 09:00 AM PST
    Speaker: Katherine (Katie) Serrano
  • NOV 11, 2015 10:30 AM PST
    Speaker: Kevin McCann, BS
    SEE ABSTRACT | Continuing Education: CE
  • NOV 11, 2015 10:30 AM PST
    Reliability of LDL cholesterol: How low can we go and when are we fooling ourselves?
    Speaker: Jeffrey Meeusen, PhD, DABCC
  • NOV 11, 2015 10:30 AM PST
    Speaker: Ravinder Singh, PhD
  • NOV 11, 2015 12:00 PM PST
    Speaker: Michael Rocco, MD
  • NOV 11, 2015 12:00 PM PST
    Speaker: Matthew Keyser, MS
    SEE ABSTRACT | Continuing Education: CE
  • NOV 11, 2015 01:30 PM PST
    Kevin Martin, MD, MB, BCh, FASN
    Professor of Internal Medicine, Director of the Divisio...
    Stuart Sprague, DO, FACP, FASN, FNKF
    Chief of the Division of Nephrology and Hypertension, a...
  • NOV 11, 2015 01:30 PM PST
    Speaker: Wieslaw Furmaga, MD
  • NOV 11, 2015 03:00 PM PST
    Speaker: Jerry Stringham, MBA
  • NOV 12, 2015 06:00 AM PST
    Speaker: Brian Jackson
  • NOV 12, 2015 07:30 AM PST
    Speaker: Edward Hook, III, MD
  • NOV 12, 2015 09:00 AM PST
    Speaker: Benjamin Solomon, MD
  • NOV 12, 2015 09:00 AM PST
    Speaker: Michael Olin
    SEE ABSTRACT | Continuing Education: CE
  • NOV 12, 2015 10:30 AM PST
    Speaker: Damien Gruson, PhD
  • NOV 12, 2015 10:30 AM PST
    Speaker: Allison Chambliss, PhD
    SEE ABSTRACT | Continuing Education: CE
  • NOV 12, 2015 10:30 AM PST
    Speaker: Doug Jeffery, PhD
  • NOV 12, 2015 12:00 PM PST
    SEE ABSTRACT | Continuing Education: CE
    Michael Laposata, MD, PhD
    Chairman of Pathology, University of Texas Medical Bran...
    Julie Taylor, PhD, MS
    Project Lead for Clinical Laboratory Integration into H...
  • NOV 12, 2015 01:30 PM PST
    Speaker: Ben Howden, PhD
  • NOV 12, 2015 01:30 PM PST
    Speaker: Jennifer Fostel, MS
  • NOV 12, 2015 01:30 PM PST
    Howard Morris, PhD, FAACB, FFSc(RCPA)
    Professor of Endocrine Bone Research Laboratory, Univ o...
    David R Sullivan, MBBS, FRACP, FRCPA
    Clinical Associate Professor, Dept of Biochemistry, Roy...
  • Clinical application of LC-MS/MS
  • NOV 11, 2015 06:00 AM PST
    Speaker: Ping Wang, PhD, DABCC, FACB
    SEE ABSTRACT | Continuing Education: CE
  • NOV 11, 2015 10:30 AM PST
    Speaker: Ravinder Singh, PhD
  • Clinical Next-generation Sequencing
  • NOV 11, 2015 06:00 AM PST
    Speaker: Christina (Tina) Lockwood, PhD, DABCC, FACB
  • Industry
  • NOV 11, 2015 06:00 AM PST
    Speaker: Raed Samara, PhD
    SEE ABSTRACT | Continuing Education: CE
  • NOV 11, 2015 07:30 AM PST
    Speaker: Linda Thienpont, PhD, PHARM, Clinical Chemist
    SEE ABSTRACT | Continuing Education: CE
  • NOV 11, 2015 10:30 AM PST
    Speaker: Kevin McCann, BS
    SEE ABSTRACT | Continuing Education: CE
  • NOV 11, 2015 12:00 PM PST
    Speaker: Matthew Keyser, MS
    SEE ABSTRACT | Continuing Education: CE
  • NOV 11, 2015 01:30 PM PST
    Kevin Martin, MD, MB, BCh, FASN
    Professor of Internal Medicine, Director of the Divisio...
    Stuart Sprague, DO, FACP, FASN, FNKF
    Chief of the Division of Nephrology and Hypertension, a...
  • NOV 12, 2015 09:00 AM PST
    Speaker: Benjamin Solomon, MD
  • NOV 12, 2015 09:00 AM PST
    Speaker: Michael Olin
    SEE ABSTRACT | Continuing Education: CE
  • NOV 12, 2015 10:30 AM PST
    Speaker: Damien Gruson, PhD
  • NOV 12, 2015 01:30 PM PST
    Speaker: Jennifer Fostel, MS
  • FDA regulation of Laboratory Developed Tests
  • NOV 11, 2015 09:00 AM PST
    Speaker: Katherine (Katie) Serrano
  • NOV 11, 2015 01:30 PM PST
    Speaker: Wieslaw Furmaga, MD
  • NOV 11, 2015 03:00 PM PST
    Speaker: Jerry Stringham, MBA
  • New lipid lowering guidelines- helpful or harmful?
  • NOV 11, 2015 10:30 AM PST
    Reliability of LDL cholesterol: How low can we go and when are we fooling ourselves?
    Speaker: Jeffrey Meeusen, PhD, DABCC
  • NOV 11, 2015 12:00 PM PST
    Speaker: Michael Rocco, MD
  • Laboratory Test Utilization
  • NOV 12, 2015 06:00 AM PST
    Speaker: Brian Jackson
  • NOV 12, 2015 10:30 AM PST
    Speaker: Allison Chambliss, PhD
    SEE ABSTRACT | Continuing Education: CE
  • NOV 12, 2015 12:00 PM PST
    SEE ABSTRACT | Continuing Education: CE
    Michael Laposata, MD, PhD
    Chairman of Pathology, University of Texas Medical Bran...
    Julie Taylor, PhD, MS
    Project Lead for Clinical Laboratory Integration into H...
  • NOV 12, 2015 01:30 PM PST
    Howard Morris, PhD, FAACB, FFSc(RCPA)
    Professor of Endocrine Bone Research Laboratory, Univ o...
    David R Sullivan, MBBS, FRACP, FRCPA
    Clinical Associate Professor, Dept of Biochemistry, Roy...
  • Clinical Diagnostics
  • NOV 12, 2015 07:30 AM PST
    Speaker: Edward Hook, III, MD
  • NOV 12, 2015 01:30 PM PST
    Speaker: Ben Howden, PhD
  • Clinical Genomics
  • NOV 12, 2015 10:30 AM PST
    Speaker: Doug Jeffery, PhD
Speakers

  • Linda Thienpont, PhD, PHARM, Clinical Chemist
    Professor of Analytical Chemistry, Statistics and Quality Control, Method Development and Validation; Director of the Laboratory for Analytical Chemistry ID-MS Reference Laboratory, Universit
    Biography
      Prof. Dr. Linda Thienpont has spent most of her career developing and validating reference measurement procedures, using isotope dilution-gas chromatography and liquid chromatography-mass spectrometry, for the analysis of many components in serum/plasma. These have included clinical chemistry analytes, steroid hormones, thyroid hormones, peptides and vitamin metabolites. By establishing metrological traceability and assessing trueness/accuracy hierarchically lower (routine) methods in laboratory medicine, she has worked with the eminent standardization and certification authorities, in addition to Chairing the IFCC Committee on the Standardization of Thyroid Hormones. She has worked in research projects with different IVD manufacturers world-wide and been involved in proficiency testing/External Quality Assessment Organizations, Accreditation Bodies and Governmental Offices. She has been involved in many educational campaigns and has published more than 168 scientific papers.
    • Kevin Martin, MD, MB, BCh, FASN
      Professor of Internal Medicine, Director of the Division of Nephrology, Saint Louis University School of Medicine
      Biography
        Dr. Martin is Director of the Division of Nephrology at Saint Louis University and Professor of Internal Medicine. He has served as Chairman of the General Medicine B Study Section of the National Institutes of Health. Dr. Martin's clinical research interests include parathyroid hormone, Vitamin D metabolism and secondary hyperthyroidism. He has authored 230 publications in professional journals, including The New England Journal of Medicine, Kidney International, and The American Journal of Kidney Diseases and Clinical Journal of the American Society of Nephrology.
      • Stuart Sprague, DO, FACP, FASN, FNKF
        Chief of the Division of Nephrology and Hypertension, and Director of Nephrology Research at NorthShore University HealthSystem and Clinical Professor of Medicine at the University of Chicago
        Biography
          Dr. Sprague is Chief of the Division of Nephrology and Hypertension, and Director of Nephrology Research at NorthShore University HealthSystem and Clinical Professor of Medicine at the University of Chicago Pritzker School of Medicine, Chicago, IL. USA. His clinical focus includes chronic kidney disease, end-stage renal failure, chronic kidney disease-mineral and bone disease, hyperparathyroidism, and osteoporosis in chronic kidney disease.
        • Damien Gruson, PhD
          Professor, Associated Laboratory Director, Saint-Luc University Hospital, Brussels, Belgium
          Biography
            Professor Damien Gruson was awarded his degree of Pharmacist and later of Specialist in Laboratory Medicine from the Catholic University of Louvain, Brussels, Belgium. He joined the Department of Laboratory Medicine of the St-Luc University Hospital in 2008. He is now associated laboratory director and leading Endocrine Biology. He is also member of the research unit on Endocrinolgy Diabetes and Nutrition of the Catholic University of Louvain. Pr. D. Gruson has published numerous articles in several international peer-reviewed journals. Pr. D. Gruson is a member of the committee on distance learning of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), of the IFCC task force for young scientists (Chair between 2010 and 2012 and now consultant), a member of the division of Endocrinology of the American Association of Clinical Chemistry. Pr. D. Gruson is also a Fellow of the European Society of Cardiology.
          • Edward Hook, III, MD
            Professor of Medicine/Epidemiology/Microbiology, Director, Division of Infectious Diseases, The University of Alabama at Birmingham, Department of Medicine, Division of Infectious Diseases
            Biography
              Dr. Hook is a Professor of Medicine and Epidemiology at the University of Alabama, Birmingham, and Director of the STD Control Program for the Jefferson County (Alabama) Department of Health. Dr. Hook's laboratory has emphasized diagnostic testing for Neisseria gonorrhoeae, Chlamydia trachomatis and syphilis, providing a platform for a wide variety of studies. His laboratory is one of 5 CDC-funded reference laboratories for the Gonococcal Isolate Surveillance Project which has monitored trends in gonococcal epidemiology and antimicrobial resistance in the U.S. since 1988. In addition, data generated by his laboratories have reflected collaboration with other faculty of the Infectious Diseases Division and other Departments within the School of Medicine (Obstetrics and Gynecology, Pediatrics and Microbiology) and other UAB Schools (Public Health, Social and Behavioral Sciences). Dr. Hook's recent work has included: studies of health behavior and behavioral interventions for STD/HIV risk reduction; assessment of STD epidemiology; clinical trials of new therapeutic agents; and clinical evaluation of new diagnostic tests for diagnosis of gonorrhea, chlamydial infection and syphilis. Major ongoing research efforts include his role as PI on a randomized trial evaluation of non-invasive screening for gonococcal and chlamydial infections in adolescents seeking care at hospital emergency rooms and as Protocol Chair for a randomized trial evaluation of azithromycin for treatment of syphilis.
            • Jennifer Fostel, MS
              Senior Global Product Manager, NGS, Qiagen
              Biography
                Jennifer Fostel has her masters in Molecular and Cell Biology from University of California at Berkeley. She did her graduate research in Dr. Susan Marqusee's lab where she analyzed the key properties of proteins from thermophilic and mesophilic microbial species. She has worked in next-generation sequencing for the last seven years, including management of clinical next generation sequencing projects for the Broad Institute of MIT and Harvard as well as NGS biomarker assay development for Takeda Pharmaceuticals oncology translational medicine. Today at QIAGEN Jennifer is a Senior Global Product Manager, covering a portfolio of universal workflow NGS library preparation products.
              • Raed Samara, PhD
                Global Product Manager, NGS, QIAGEN
                Biography
                  Raed Samara, PhD is a Global Product Manager for NGS technologies at QIAGEN, with a focus on pre-analytics and targeted enrichment. Prior to joining QIAGEN, he was a postdoctoral fellow at the National Cancer Institute conducting research in the field of cancer immunology with emphasis on identifying strategies to boost the efficacy of cancer vaccines. He received his Ph.D. degree from Georgetown University in tumor biology.
                • Benjamin Solomon, MD
                  Chief, Division of Medical Genomics, Inova Translational Medicine Institute, Associate Professor, Virginia Commonwealth University School of Medicine
                  Biography
                    Dr. Solomon, an accomplished scientist and medical geneticist, is dual board-certified in pediatrics and clinical genetics through the National Human Genome Research Institute. At Inova Translational Medicine Institute, Dr. Solomon leads the Medical Genomics division - a group of clinicians and researchers that focuses on providing genetic and genomic medical care, discovering new explanations for genetic disorders, and studying the best ways to integrate cutting-edge genomic resources into clinical practice. Previously Dr. Solomon held positions at National Institutes of Health researching the genetic and genomic causes of both rare and common conditions, especially certain types of congenital anomalies. The author of over 70 peer-reviewed articles and book chapters, Dr. Solomon serves as an editor on a number of medical journals, has edited several medical textbooks, and is actively involved in genetic and genomic training and education.
                  • Kevin McCann, BS
                    Application Scientist, Agilent Technologies
                    Biography
                      Kevin McCann is an application scientist at Agilent Technologies in Santa Clara, California where he focus on LC/MS workflows and solutions. He has contributed to the development of many analytical methods and customer collaborations as well as enabling technologies, such as the Agilent StreamSelect LC/MS system and MassHunter Examiner. Prior to his work at Agilent, Kevin was the laboratory manager of the biochemical genetics laboratory at Mount Sinai Hospital in New York where he also developed LC/MS methods for the analysis of warfarin, tamoxifen, acylcarnitine profiles, and amino acid profiles.
                    • Michael Olin
                      Assistant Professor, Department of Pediatrics, Division of Hematology/Oncology, University of Minnesota
                      Biography
                        For more than 7 years, I have dedicated my efforts to developing immunotherapy for brain tumors. We, among others, have utilized tumor cells as vaccine components, demonstrating promising results with minimal toxicity. However, progression to a productive immune response that necessitates passing a number of immunological checkpoints those act as barriers to effective immunotherapy because of "self" antigen recognition. The FDA-approved monoclonal antibodies ipilimumab, pembrolizumab and nivolumab, which inhibit the cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), programmed death 1 (PD1) and programmed death 1 ligand (PD-L1) checkpoints, respectively, can be used to partially overcome this limitation. Both anti-CTLA-4 and anti-PD1 act directly on T cells, whereas a third immunological checkpoint acts directly on antigen-presenting cells, inducing T-cell tolerance. This checkpoint arises from the engagement of CD200 with its receptor (CD200R). CD200 is expressed in a variety of human tumors including melanoma and glioblastomas. However, it is the soluble form of CD200 that correlates with poor patient outcomes. CD200 has been well characterized as immunosuppressive in multiple graft rejection models, but prior to our work its role in tumor-induced immune suppression had not been clearly defined. We reported that CD200 concentration significantly increased in glioma patients' sera as their tumors progressed, correlating with increases in the lineage-negative myeloid-derived suppressor cell (MDSC) population. More surprisingly, we have found that CD200 is significantly upregulated on the vascular endothelial cells forming the blood-brain barrier in malignant human brain tissue but not in adjacent, apparently unaffected tissue. We are focusing our research on the development of a competitive CD200 inhibitor (a CD200R antagonist) with the goal of overcoming CD200-induced immune suppression. Our preliminary data show that the CD200R isoform activates antigen-presenting cells; we suggest that this occurs via a CD200R isoform that enhances chemokine and cytokine production required for the development of a tumoricidal response.
                      • Matthew Keyser, MS
                        Senior Manager, NGS Applications, DNASTAR
                        Biography
                          Matthew Keyser is Senior Manager, NGS Applications for DNASTAR, where he has helped scientists address their sequence assembly and analysis challenges for the past seven years. Matts sole focus at DNASTAR is supporting customers in next-gen sequencing applications using DNASTARs broad software toolset. Matt helps customers with their templated and de novo assembly projects, transcriptomes, exomes, metagenomic assemblies, RNA-Seq, ChIP-Seq and numerous other unique experiments. Matt has helped hundreds of scientists optimize their workflows using DNASTARs next-gen software solutions. He has also spoken at numerous conferences and workshops regarding the capabilities of DNASTARs next-gen software tools.
                        • Katherine (Katie) Serrano
                          Deputy Director, Division of Chemistry and Toxicology Devices, Office of In Vitro Diagnostics and Radiological Health, Food and Drug Administration Center for Devices and Radiological Health
                          Biography
                            Katherine Serrano is the Deputy Director of FDA's Division of Chemistry and Toxicology Devices in the Office of In Vitro Diagnostic Device Evaluation and Safety. Ms. Serrano received a Bachelor of Science degree in Biomedical Engineering and a Bachelor of Arts degree in Spanish from the University of Minnesota, Twin Cities. Before working at the Food and Drug Administration, Ms. Serrano has held positions as a regulatory affairs professional at Boston Scientific Corporation and has worked as a Biomedical Engineer at the United States National Institutes of Health supporting new programs focused on cutting edge technologies in the field of bioengineering. Ms. Serrano joined the FDA in 2008 as a Commissioner's fellow where she worked on various policy issues related to in vitro diagnostics. At FDA, Ms. Serrano has worked as a scientific reviewer, the Chief of the Diabetes Diagnostic Devices Branch and as the Deputy Director for the Division of Chemistry and Toxicology Devices.
                          • Michael Laposata, MD, PhD
                            Chairman of Pathology, University of Texas Medical Branch
                            Biography
                              Dr. Michael Laposata is the Edward and Nancy Fody Professor of Pathology and Medicine at Vanderbilt University School of Medicine. He is the pathologist-in-chief at Vanderbilt University Hospital and director of clinical laboratories. He received his M.D. and Ph.D. from Johns Hopkins University School of Medicine and completed a postdoctoral research fellowship and residency in Laboratory Medicine (Clinical Pathology) at Washington University School of Medicine in St. Louis. He took his first faculty position at the University of Pennsylvania School of Medicine in Philadelphia in 1985, where he was an Assistant Professor and director of the hospital's coagulation laboratory. In 1989, he became Director of Clinical Laboratories at the Massachusetts General Hospital and was appointed to faculty in pathology at Harvard Medical School. His research program, with more than 160 peer reviewed publications, has focused on fatty acids and their metabolites. His research group is focused on the study of fatty acid alterations in cystic fibrosis. Dr. Laposata's clinical expertise is in the field of blood coagulation, with a special expertise in the diagnosis of hypercoagulable states. Dr. Laposata implemented a system whereby the clinical laboratory data in coagulation and other areas of laboratory medicine are systematically interpreted with the generation of a patient specific narrative paragraph by a physician with expertise in the area. This service is essentially identical to the service provided by physicians in radiology and anatomic pathology, except that it involves clinical laboratory test results. In 2005, Dr. Laposata was recognized by the Institute of Quality in Laboratory Medicine of the Centers for Disease Control and Prevention for this innovation. Dr. Laposata is the recipient of 14 major teaching prizes at Harvard, the Massachusetts General Hospital, and the University of Pennsylvania School of Medicine. His recognitions include the 1989 Lindback award, a teaching prize with competition across the entire University of Pennsylvania system; the 1998 A. Clifford Barger mentorship award from Harvard Medical School; election to the Harvard Academy of Scholars in 2002, and to the Vanderbilt University School of Medicine Academy for Excellence in Teaching in 2009; and the highest award - by vote of the graduating class - for teaching in years 1 and 2 at Harvard Medical School in 1999, 2000, and 2005.
                            • Julie R Taylor, PhD, MS
                              Project Lead for the Clinical Laboratory Integration into Health Care Collaboration (CLIHC), Division of Laboratory Programs, Standards, and Services Center for Surveillance, Epidemiology, an
                              Biography
                                Julie received her B.S. degree in microbiology from the University of Alabama focusing on research in bacterial genetics then completed her M. S. and Ph.D. in microbiology at Auburn University where she studied immunity to bacteria and parasites. She gained experience in virology during a postdoctoral program at Emory University School of Medicine.  Throughout her years of working in the private sector in laboratory and clinical research settings, Julie has identified, developed and completed programs addressing unmet needs in health care.    Her accomplishments include patents and FDA- or USDA- licensed medical devices, vaccines, and diagnostics.  She has developed both commercial and research diagnostics for detecting antigens, antibodies and cellular immunity. Julies research experience includes the areas of virology, immunology, parasitology, mycology, genetics and oncology.  She has worked nationally and internationally with professionals from hospitals, long term and home care institutions, academic institutions, medical device and pharmaceutical industries, State Public Health Departments, the World Health Organization, and the International Organization of Standards.  She has also served as a reviewer for health care journals.  These professional partnerships have resulted in journal publications, healthcare standards, and training programs.   Julie is currently the Project Lead for the Clinical Laboratory Integration into Health Care Collaboration (CLIHC)TM from the Division of Laboratory Programs, Standards, and Services at the Centers for Disease Control and Prevention (CDC).  She coordinates programs to improve laboratory quality by enhancing the capacity, infrastructure, and capabilities of laboratories worldwide.   
                              • Christina (Tina) Lockwood, PhD, DABCC, FACB
                                Associate Director, Genetics and Solid Tumor Diagnostics Laboratory, Assistant Professor, Department of Laboratory Medicine, University of Washington
                                Biography
                                  Dr. Lockwood joined the Department of Laboratory Medicine as an Associate Director of the Genetics and Solid Tumor Diagnostics Laboratory at the University of Washington Medical Center in 2014. She is a Diplomate of the American Board of Clinical Chemistry and an Active Candidate of the American Board of Medical Genetics and Genomics. After obtaining her PhD at the University of Wisconsin, Dr. Lockwood completed postdoctoral fellowship training in Clinical Chemistry and Clinical Molecular Genetics at the Washington University School of Medicine in St. Louis, MO. Her interests include the development and application of molecular methods for the detection of genomic alterations in genetic disease, hematologic malignancies, and solid tumors. Dr. Lockwood has also been active in the design and implementation of educational resources related to training in genomic medicine.
                                • Allison Chambliss, PhD
                                  Clinical Chemistry Fellow, Department of Pathology, Johns Hopkins University School of Medicine
                                  Biography
                                    Allison Chambliss, PhD is a Clinical Chemistry Fellow in the Department of Pathology at the Johns Hopkins University School of Medicine. She received her B.S. in Chemical Engineering from Virginia Tech and her PhD in Chemical & Biomolecular Engineering from Johns Hopkins University. Allison's current clinical research interests include development of rapid, targeted pharmacogenetics assays and mass spectrometry methods. Her current training areas include operation of the clinical laboratory, quality control and assurance, laboratory management, analytical methodologies, and test interferences.
                                  • Wieslaw Furmaga, MD
                                    Associate Professor, University of Texas Health Science Center at San Antonio
                                    Biography
                                      I graduated from the Collegium Medicum at Jagiellonski University in Poland, and subsequently completed residency program in anatomic, clinical pathology and clinical chemistry. I have been practicing pathology in the University of Texas Health Science Center at San Antonio, Texas as a staff pathologist and medical director of clinical chemistry and molecular laboratory. I have been serving the Instrumental Resource Committee of the College of American Pathologist (CAP) since 2008. Since 2009 I have served for the Pharmacogenomics Committee, Educational subcommittee working on Pharmacogenomics Educational Course. I was actively involved in the CLSI on a project "Method Validation by using patient's sample". The main scientific interest is in biomarkers for aggressive prostate cancer as well as biomarkers for monitoring the trauma patients with hemorrhagic shock.
                                    • Ben Howden, PhD
                                      Professor, Head of Laboratory, Microbiology and Immunology, Director, Microbiological Diagnostic Unit, University of Melbourne
                                      Biography
                                        The Howden Laboratory, located in the Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity is closely affiliated with the Microbiological Diagnostic Unit Public Health Laboratory (MDU PHL). Professor Howden is an Infectious Diseases Physician and Medical Microbiologist who is Director of the MDU PHL and Head of the Research Laboratory. The Howden Laboratory works in close collaboration with the Stinear Laboratory, and has close links with the Infectious Diseases and Microbiology Units at Austin Hospital. Our research uses genomics, molecular biology, epidemiology and clinical studies to addresses a broad range of issues related to invasive bacterial diseases in humans, especially those caused by staphylococci, enterococci and other antimicrobial-resistant species. Additionally, working closely with scientists in the MDU PHL, we investigate the evolution, epidemiology and spread of bacterial pathogens of public health significance such as Neisseria gonorrhoea, Listeria monocytogenes, Shigella and Salmonella spp. and Legionella spp.
                                      • Brian Jackson
                                        Associate Professor of Pathology (Clinical), Medical Director of Informatics, ARUP Laboratories, University of Utah, Department of Pathology
                                        Biography
                                          Dr. Jackson directs the Informatics Department at ARUP, including ARUP Consult®, decision support, product management, informatics software development, and ATOP® consulting. He is also the medical director for Referral Testing and an associate professor of pathology at the University of Utah. He received his BA in mathematics, his MS in medical informatics, and his MD from the University of Utah, and completed a clinical pathology residency at Dartmouth-Hitchcock Medical Center. Prior to his employment at ARUP, Dr. Jackson was a staff clinical pathologist and informaticist at Dartmouth-Hitchcock Medical Center, a product manager for a Belgium-based medical software firm, and a National Library of Medicine informatics fellow at the University of Utah. Dr. Jackson's research interests include economic analysis of diagnostic testing and physician utilization of laboratory tests. He is certified in clinical pathology by the American Board of Pathology.
                                        • Doug Jeffery, PhD
                                          Scientific Reviewer, Food and Drug Administration Center for Devices and Radiological Health
                                          Biography
                                            Senior Staff Fellow, Office of In Vitro Diagnostics and Radiological Health, Food and Drug Administration Center for Devices and Radiological Health. I received a Bachelor of Science degree in biology from the Massachusetts Institute of Technology and a Ph.D. in biochemistry from the University of California, San Francisco. Before working at the FDA, I worked at the Novartis Institutes of Biomedical Research performing basic research in oncology target discovery.
                                          • Jeffrey Meeusen, PhD, DABCC
                                            Co-Director, Cardiovascular Laboratory Medicine, Mayo Clinic
                                            Biography
                                              Dr. Meeusen received a PhD from the University of Wisconsin studying inorganic biochemistry. After graduate school he spent three years as a post-doctoral research fellow supporting Mayo Medical Laboratories esoteric test development. Dr. Meeusen's research interests include lipid and lipoprotein testing and he is currently co-director of Cardiovascular Laboratory Medicine at Mayo Clinic.
                                            • Howard Morris, PhD, FAACB, FFSc(RCPA)
                                              Professor of Endocrine Bone Research Laboratory, Univ of South Australia
                                              Biography
                                                Professor Howard Morris is Professor of Medical Sciences at the University of South Australia and a Chief Medical Scientist in Chemical Pathology at SA Pathology, Adelaide, South Australia. He is currently Vice-President of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and Chair of the IFCC-International Osteoporosis Foundation Working Group on Standardization of Bone Marker Assays. He has over 30 years experience in Clinical Biochemistry largely managing the Endocrinology laboratory of a large public pathology service. Between 2003 and 2009 he was the Director of the Hanson Institute in Adelaide, the major medical research institute in South Australia. His research investigates the pathophysiology of osteoporosis and the effects of hormones including vitamin D and dietary calcium. He was the Louis Avioli Memorial Lecturer at the 2009 Annual Scientific Meeting of the American Society for Bone and Mineral Research. He is also Chair of the South Australian Department of Health Working Party on Osteoporosis and Fracture Prevention.
                                              • Michael Rocco, MD
                                                Medical Director of Cardiac Rehabilitation and Stress Testing, Staff Cardiologist, Cleveland Clinic
                                                Biography
                                                  Michael Rocco, MD, is the Medical Director of Cardiac Rehabilitation and Stress Testing, Section of Preventive Cardiology, and a Staff Cardiologist, Section of Clinical Cardiology and Preventive Cardiology, in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine. He also holds an appointment in the Section of Nuclear Cardiology in the Department of Molecular and Functional Imaging. He is board-certified in internal medicine, cardiology and nuclear cardiology. Dr. Rocco has a special interest in clinical cardiology, stress testing and cardiac rehabilitation, coronary artery disease, cardiac catheterization and the treatment of lipid disorders. Dr. Rocco did his undergraduate work at Georgetown University in Washington, D.C., graduating Phi Beta Kappa and valedictorian of his class. He received his medical degree from Duke University Medical Center in Durham, N.C., where he was inducted into the Alpha Omega Alpha Medical Honor Society. He took his clinical training (internship and residency) at Brigham & Women's Hospital in Boston. He became a Research/Clinical Fellow in Cardiology at Brigham & Women's Hospital and at Harvard Medical School. Dr. Rocco completed the Henry J. Kaiser Fellowship Program at Harvard University, Boston, where he trained in epidemiology, biostatistics and clinical study design.
                                                • Ravinder Singh, PhD
                                                  Director, Endocrine Laboratory, Mayo Clinic
                                                  Biography
                                                    Ravinder J. Singh, Ph.D., is the director of the Mayo Clinic Endocrine Laboratory. He has a focused area of investigation that has broad applicability to the field. Dr. Singh studies the application of liquid chromatography-tandem mass spectrometry (LC-MS/MS) to clinical laboratory analysis. Many of the methods that Dr. Singh developed are now considered reference methods. They have subsequently been utilized for method standardization efforts as well as to establish clinical disease correlates, which he has published with his collaborators. Dr. Singh's work has directly contributed to improving methods for the clinical diagnosis of Cushing's disease, pheochromocytoma and congenital adrenal hyperplasia. He continues to work to discover innovative ways to better understand the uses of LC-MS/MS in providing patients with faster and more accurate diagnoses.
                                                  • Jerry Stringham, MBA
                                                    President, Medical Technology Partners
                                                    Biography
                                                      Jerry Stringham has worked as a reimbursement strategy consultant since the 1980s, when he began providing reimbursement consulting to diverse medical and pharmaceutical companies. Jerry holds a BS in mechanical engineering from the Massachusetts Institute of Technology and an MBA from Harvard Business School. He has been part of five medical device start-up organizations operating out of New England and has grown MTP's client list to over 140 clients. Jerry founded Medical Technology Partners in 1998 to fill the growing need for business-oriented reimbursement consulting. Jerry's experience in industry, including as a Principal in the health economics practice of a major CRO, brings expertise to new technology reimbursement challenges.
                                                    • David R Sullivan, MBBS, FRACP, FRCPA
                                                      Clinical Associate Professor, Dept of Biochemistry, Royal Prince Alfred Hospital
                                                      Biography
                                                        David Sullivan is a physician and chemical pathologist in the Department of Clinical Biochemistry at Royal Prince Alfred Hospital.  This includes conjoint appointment as Clinical Associate Professor, Central Clinical School, Faculty of Medicine and Charles Perkins Centre, University of Sydney. David has a long-term interest in lipid metabolism with particular emphasis on the gene environment interactions contributing to cardiovascular disease. He has been involved in the early use of many forms of lipid-lowering intervention. He remains a national leader of efforts to improve the detection and management of severe inherited dyslipidaemia, such as that seen in Familial Hypercholesterolaemia. David has experience in several international clinical posts, including World Health Organization (WHO) Fellowship at the MRC Lipoprotein Unit, Royal Postgraduate School of Medicine, Hammersmith Hospital, London and co-ordination of international clinical studies from the WHO reference lipid laboratory in Wageningen, Netherlands. In addition to his clinical activities in Australia, he has served on numerous clinical committees including the management committees of the LIPID and FIELD trials. Current research interests are focussed on biomarkers, post-prandial metabolism and novel therapies.
                                                      • Ping Wang, PhD, DABCC, FACB
                                                        Director of Clinical Chemistry, Houston Methodist Hospital, Associate Professor, Pathology and Laboratory Medicine, Weill Cornell Medical College
                                                        Biography
                                                          Dr. Ping Wang is currently the Medical Director of Clinical Chemistry at Houston Methodist Hospital and Associate Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College. She is also Director of the ComACC-accredited Postdoctoral Fellowship Program at Houston Methodist Hospital. Dr. Wang was trained at Tsinghua University, University of Wisconsin-Madison and UCSF. She is board certified in Clinical Chemistry, Molecular Diagnostics and Toxicological Chemistry by American Board of Clinical Chemistry, for which she currently serves as Vice President and Chair of Examination Committee. She is a fellow of the National Academy of Clinical Biochemistry. She currently serves or had served on the boards of NACCCA, AACC LVDD division and TDM and Toxicology division. Dr. Wang has received many honors and awards including the Career Cornerstone Award, NACB Distinguished Abstract Award and AACC Outstanding Research Award. She has published over 60 peer-reviewed papers, abstracts and book chapters. Dr. Wang has over 10 years of experience directing and managing high complexity CLIA clinical laboratories, and is an expert in CLIA regulations, laboratory management to drive clinical efficiency, quality and outcome, clinical assay development, optimization and execution in a highly regulated environment. Besides clinical service and teaching, Dr. Wang's current research interests focus on translating novel research and start-up findings into clinical diagnostic tools. She is Principle Investigator of two NIH grants, and actively collaborates with major diagnostic companies as well as start-up ventures to develop next-generation diagnostic tools.
                                                        Sponsored By

                                                        For information on becoming a sponsor or exhibitor, please click here.


                                                        Continuing Education (CME/CE/CEU) Credits

                                                        The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                                        Committee

                                                        To download the Program Committee brochure here.


                                                        • Stephanie Willerth, PhD

                                                          Dr. Willerth currently holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she is dually appointed in the Department of Mechanical Engineering and Division of Medical Sciences. Her research group investigates how to engineer neural tissue ...

                                                          See more See less
                                                        • C Jimmy Lin, MD, PhD, MHS

                                                          Jimmy Lin, MD, PhD, MHS, is a 2012 TED Fellow and Founder & President of Rare Genomics Institute, the world's first platform to enable any community to leverage cutting-edge biotechnology to advance understanding of any rare disease. Partnering with 18 of the top medical ...

                                                          See more See less
                                                        • Agnieszka Lichanzka Ph.D.

                                                          Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

                                                          See more See less
                                                        • Martin Latterich, PhD

                                                          The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

                                                          See more See less
                                                        • Fred Russell Kramer, PhD

                                                        • Daniel Irimia, MD, PhD

                                                        • Ulrich Hengst, PhD

                                                          Dr. Ulrich Hengst studied biochemistry at the Ruhr University Bochum, Germany, and conducted his graduate research at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, in the group of Prof. Denis Monard. In 2003 he received his PhD from the ...

                                                          See more See less
                                                        • Timothy Harris, PhD

                                                          Since June 2011, Dr. Harris has served as the Senior Vice President of Translational Medicine at Biogen Idec. Dr. Harris has served as the Director of the Advanced Technology Program at SAIC Frederick since 2007 and Chief Technology Officer for SAIC Frederick since 2008. Prior to ...

                                                          See more See less
                                                        • Anthony Grace, PhD

                                                          Dr. Anthony A. Grace is a Distinguished Professor of Neuroscience and a Professor of Psychiatry and Psychology at the University of Pittsburgh in Pittsburgh, PA. He received his Ph.D. from Yale University School of Medicine with Dr. Benjamin S. Bunney and had postdoctoral ...

                                                          See more See less
                                                        • Pierre-Antoine Gourraud, PhD, MPH

                                                          Pierre-Antoine Gourraud is a former student of the Ecole Normale Suprieure de Lyon in France. After receiving an M.P.H. from University Paris XIII in 2002, he got his Ph.D. in Immunogenetic Epidemiology and Public Health from Toulouse University in 2005. He relocated to the ...

                                                          See more See less
                                                        • Eric Gluck, MD, JD

                                                        • Ariel Louwrier PhD

                                                          Successful Senior Scientific Business Executive with demonstrated expertise growing markets, revenues, product pipelines and expanding technical organizations into new business opportunities. Educational and business management experience in global markets, with quantified ...

                                                          See more See less
                                                        • Tatjana Matejic, PhD, D(ABMLI)

                                                        • Kathryn Wellen, PhD

                                                        • Katerina Venderova, PharmD, PhD

                                                          Dr. Katerina Venderova obtained her master's and doctorate degrees in pharmacy, and her PhD in Toxicology from Charles University in the Czech Republic. She then received a fellowship from the Parkinson Society Canada and pursued her postdoctoral training at Toronto Western ...

                                                          See more See less
                                                        • Theral Timpson

                                                        • Deanne Taylor, MS, PhD

                                                          Dr. Taylors background is in biophysics, bioinformatics, computational biology and structural biology with emphasis on human genetics and translational medicine. She obtained her Ph.D. in Biophysics from the University of Michigan, Ann Arbor, and completed a postdoctoral ...

                                                          See more See less
                                                        • Leigh Anne Swayne, PhD

                                                        • Ahmad Salehi, MD, PhD

                                                          Ahmad Salehi, M.D., Ph.D. is a Clinical Associate Professor at the Department of Psychiatry and Behavioral Sciences, Stanford Medical School and the Director of the Translational Laboratory at the VA Palo Alto Health Care System in California. He obtained his MD in Tehran, Iran ...

                                                          See more See less
                                                        • John Quackenbush, PhD

                                                          John Quackenbush received his PhD in 1990 in theoretical physics from UCLA working on string theory models. Following two years as a postdoctoral fellow in physics, Dr. Quackenbush applied for and received a Special Emphasis Research Career Award from the National Center for ...

                                                          See more See less
                                                        • Judd Moul, MD, FACS

                                                          Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

                                                          See more See less
                                                        • Vincent Mauro, Ph.D.

                                                          Dr. Mauro is an Associate Professor in the Department of Neurobiology at the Scripps Research Institute in La Jolla, California. He is also a co-founder and lead scientist of Promosome, a biotechnology company focused on bioproduction enablement and DNA vaccines. In addition, Dr ...

                                                          See more See less
                                                        • Paul Mathews, PhD

                                                          Dr. Paul J. Mathews received his bachelors degree from the University of Oregon where he studied invertebrate behavioral plasticity in the lab of Dr. Nathan Tublitz. He received his Ph.D. in neuroscience from the University of Texas at Austin under the mentorship of Dr. Nace ...

                                                          See more See less
                                                        • Wieslaw Furmaga, MD

                                                          Director, Clinical Chemistry Laboratory University Hospital Director, General Laboratory Cancer Treatment Research Center Director, Proteomics Laboratory UTHSC at San Antonio Interim Director, Molecular Laboratory UTHSC at San Antonio Associate Director, Mycology Laboratory UTHSC ...

                                                          See more See less
                                                        • David Carpentieri, MD

                                                        • Howard Morris, PhD, FAACB, FFSc(RCPA)

                                                          Professor Howard Morris is Professor of Medical Sciences at the University of South Australia and a Chief Medical Scientist in Chemical Pathology at SA Pathology, Adelaide, South Australia. He is currently Vice-President of the International Federation of Clinical Chemistry ...

                                                          See more See less
                                                        • Ross J Molinaro, PhD, MT(ASCP), DABCC, FACB

                                                          Ross J. Molinaro, PhD, MT(ASCP), DABCC, FACB is an Assistant Professor in the Department of Pathology and Laboratory Medicine at Emory University. He received his PhD in Clinical Chemistry and Molecular Medicine from Cleveland State University and completed the ComACC training ...

                                                          See more See less
                                                        • Mark Marzinke, PhD, BABCC

                                                          Mark Marzinke, PhD, DABCC earned a Ph.D. in Biochemistry from the University of Wisconsin-Madison and subsequently completed a clinical chemistry fellowship at The Johns Hopkins University in 2012. During his clinical fellowship, Dr. Marzinke focused on the development and ...

                                                          See more See less
                                                        • Alan Maisel, MD

                                                          Dr. Alan Maisel attended University of Michigan Medical School and did his cardiology training at the University of California at San Diego. He is currently Professor of Medicine at the University and director of the coronary care unit and the heart failure program at the ...

                                                          See more See less
                                                        • Kamisha Johnson-Davis, PhD, DABCC, FACB

                                                          Dr. Johnson-Davis is a medical director of the Clinical Toxicology laboratory, Antifungal Testing and Immunosuppressants Testing at ARUP. Dr. Johnson-Davis received her PhD in pharmacology at the University of Utah and is board certified in clinical chemistry by the American ...

                                                          See more See less
                                                        • Bruce Hollis, PhD

                                                          Bruce W. Hollis, Ph.D. received his B.Sc. and M.Sc. from the Ohio State University and subsequently his Ph.D. from the University of Guelph in 1979. Dr. Hollis then completed an Endocrine Fellowship at The Case Western Reserve University School of Medicine in 1982. Dr. Hollis ...

                                                          See more See less
                                                        • Michael Holick, MD, PhD

                                                          Michael F. Holick, Ph.D., M.D. is Professor of Medicine, Physiology and Biophysics; Director of the General Clinical Research Unit; and Director of the Bone Health Care Clinic and the Director of the Vitamin D, Skin and Bone Research Laboratory at Boston University Medical ...

                                                          See more See less
                                                        • George Fritsma, MS, MT

                                                          George Fritsma is an associate professor in Laboratory Medicine of the Department of Pathology at the University of Alabama at Birmingham. Prof. Fritsma manages www.fritsmafactor.com, "The Fritsma Factor, Your Interactive Hemostasis Resource," a clinical coagulation ...

                                                          See more See less
                                                        • Cynthia Bowman MD

                                                          Dr. Cynthia Bowman has been a broad based general pathologist for over 30 years. She graduated with a BA in Chemistry from St. Olaf College, received her MD from Vanderbilt University Medical School, and trained for 6 years at the University of California, San Francisco as a ...

                                                          See more See less
                                                        • Christoph H. Borchers, Ph.D.

                                                          Dr. Borchers received his B.S., M.S. and Ph.D. from the University of Konstanz, Germany. After his post-doctoral training and employment as a staff scientist at NIEHS/NIH/RTP, NC and he was the director of the Duke - UNC Proteomics Facility and held a faculty position at UNC ...

                                                          See more See less
                                                        • Amy K Saenger, PhD, DABCC, FACB

                                                        • Joely Straseski, PhD, MS, MT(ASCP), DABCC

                                                          Dr. Straseski is a medical director of endocrinology at ARUP Laboratories and an assistant professor of pathology at the University of Utah School of Medicine. She received her PhD in pathology and laboratory medicine and a Master's degree in bacteriology from the University of ...

                                                          See more See less
                                                        • Charles Cantor, PhD

                                                          Dr. Charles Cantor is a founder, and Chief Scientific Officer at SEQUENOM, Inc., which is a genetics discovery company with tools, information and strategies for determining the medical impact of genes and genetic variations. He is also the founder of SelectX Pharmaceuticals ...

                                                          See more See less
                                                        • Peter Blume-Jensen, MD, PhD

                                                          Dr. Peter Blume-Jensen has extensive expertise in basic and translational cancer research, oncogenic signaling, and targeted oncology therapeutics drug discovery prior to joining Metamark as CSO in 2010.  From 2001 to 2008 Peter was department head at first Serono, US and ...

                                                          See more See less
                                                        • Josip Blonder, MD

                                                          Dr. Blonder leads the Clinical Proteomics Group at the CRTP/FNL. FNL is a Federally Funded Research and Development Center operated by Leidos Biomedical Research, Inc., for the National Cancer Institute (NCI). In 1978, Dr. Blonder received his M.D. at the Rijeka University ...

                                                          See more See less
                                                        • Joan W Bennett, PhD

                                                        • Pinar Bayrak-Toydemir, MD, PhD

                                                          Dr. Bayrak-Toydemir is the medical director of the Molecular Genetics and Genomics Laboratories at ARUP and an associate professor of pathology at the University of Utah School of Medicine. Dr. Bayrak-Toydemir received her MD from the Ankara University School of Medicine in ...

                                                          See more See less
                                                        • Szczepan Baran, VMD, MS

                                                          Dr. Szczepan Baran is the Global Head, Animal Welfare and Compliance Training at Novartis Institutes for Biomedical Research. Dr. Baran received a Bachelor of Science in Pre-Veterinary Medicine from the University of Delaware, a Veterinary Medical Doctoral degree from the ...

                                                          See more See less
                                                        • Antonio Baines, PhD

                                                          Dr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...

                                                          See more See less
                                                        • R. Claudio Aguilar, Ph.D.

                                                          Dr. Aguilar obtained his PhD degree in Immunochemistry from the School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. Dr. Aguilar pursued his post-doctoral training at the National institutes of Health in Bethesda, MD in the lab of the well-known cell ...

                                                          See more See less
                                                        • Ottavio Arancio MD, Ph.D

                                                          Dr. Ottavio Arancio received his Ph.D and M.D. from the University of Pisa (Italy). From 1981 to 1986 he took residency training in Neurology at the University of Verona (Italy). Dr. Arancio has held Faculty appointments at Columbia University, NYU School of Medicine and at ...

                                                          See more See less
                                                        • Alan Wright, MD

                                                          Dr. Wright is the Chief Medical Officer at Roche Diagnostics Corporation in Indianapolis, Indiana. Prior to joining Roche, Dr. Wright served as Senior Vice President of Health Improvement Strategies for Miraca Life Sciences. He was the Vice President for Product Strategy and ...

                                                          See more See less
                                                        • Sihe Wang, PhD DABCC FACB

                                                          Dr. Sihe Wang is Section Head and Medical Director of Clinical Biochemistry and Director of Clinical Biochemistry Fellowship Training Program, Cleveland Clinic, Cleveland, Ohio. He also chairs the clinical chemistry integration effort for the Cleveland Clinic Health System which ...

                                                          See more See less
                                                        Help

                                                        General LabRoots Questions

                                                        For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                                        Contact us

                                                        Virtual Events and Webinars

                                                        Supported Configurations

                                                        • Operating System Internet Explorer Firefox Chrome Safari
                                                          Vista IE8+ FF10+ Chrome15+
                                                          Windows 7 IE8+ FF10+ Chrome15+
                                                          Windows 8 IE10 FF10+ Chrome15+
                                                          Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                        • Cookie settings: session cookies enabled
                                                        • Browser configuration must have JavaScript enabled
                                                        • Adobe Flash player 10.2 or later

                                                        To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                        Internet Connection

                                                        • A minimum of 100Kbps is recommended for audio-only events
                                                        • A minimum of 300Kbps is recommended for speaker on-video events

                                                        Computer Equipment

                                                        • Screen Resolution: Minimum 1024x768
                                                        • Video Card: 65,000 colors minimum
                                                        • Sound card and speakers (or headphones) for hearing webcast in full format
                                                        • Audio Card: 16-bit minimum
                                                        • RAM: 512MB of free RAM

                                                        Firewall Protocol

                                                        • HTTP on port 80 or HTTPS on port 443
                                                        • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                        • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                        Work-At-Home Attendees

                                                        • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                        For A Seamless Experience

                                                        When using a mobile device, FREE Mobile Apps are available:

                                                        - For viewing Webinars:

                                                        - For viewing Virtual Events

                                                        Attendee Guide

                                                        • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                        Virtual Event and Webinar Support:

                                                        Continuing Education (CME/CE) Support

                                                        Loading Comments...